Edith Mitchell

592 total citations
24 papers, 462 citations indexed

About

Edith Mitchell is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Edith Mitchell has authored 24 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Edith Mitchell's work include Colorectal Cancer Treatments and Studies (10 papers), Immunotherapy and Immune Responses (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Edith Mitchell is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Immunotherapy and Immune Responses (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Edith Mitchell collaborates with scholars based in United States, Germany and Italy. Edith Mitchell's co-authors include Deborah G. Rose, Pramila R. Anné, Mario E. Lacouture, Robert D. Fry, Scott D. Goldstein, Najjia N. Mahmoud, Gerald A. Isenberg, David E. Stein, Román Pérez-Soler and Eric Van Cutsem and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Edith Mitchell

23 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edith Mitchell United States 11 321 155 89 67 63 24 462
Jeltje Schulten Germany 10 334 1.0× 173 1.1× 222 2.5× 117 1.7× 48 0.8× 14 603
Peey‐Sei Kok Australia 14 252 0.8× 90 0.6× 236 2.7× 35 0.5× 69 1.1× 38 555
Matthew E. Witek United States 14 214 0.7× 177 1.1× 146 1.6× 111 1.7× 72 1.1× 50 578
Claudio Flores Peru 11 278 0.9× 60 0.4× 136 1.5× 85 1.3× 77 1.2× 41 493
Theresa Neumann United States 7 864 2.7× 58 0.4× 91 1.0× 83 1.2× 33 0.5× 10 963
Hua‐Ling Tsai United States 11 140 0.4× 108 0.7× 97 1.1× 51 0.8× 27 0.4× 44 494
Leonidas Apostolidis Germany 13 358 1.1× 62 0.4× 95 1.1× 42 0.6× 48 0.8× 51 566
М. Yu. Fedyanin Russia 8 198 0.6× 83 0.5× 104 1.2× 41 0.6× 59 0.9× 107 308
Dayssy A. Diaz United States 12 151 0.5× 118 0.8× 114 1.3× 50 0.7× 24 0.4× 47 388
Hakaru Tadokoro Brazil 10 369 1.1× 43 0.3× 237 2.7× 83 1.2× 35 0.6× 33 514

Countries citing papers authored by Edith Mitchell

Since Specialization
Citations

This map shows the geographic impact of Edith Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Mitchell more than expected).

Fields of papers citing papers by Edith Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edith Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Mitchell. The network helps show where Edith Mitchell may publish in the future.

Co-authorship network of co-authors of Edith Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of Edith Mitchell. A scholar is included among the top collaborators of Edith Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edith Mitchell. Edith Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Catalano, Paul, Steven J. Cohen, Barbara Burtness, et al.. (2023). Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial. The Oncologist. 28(9). 827–e822. 1 indexed citations
2.
Perkins, Rebecca B. & Edith Mitchell. (2023). Cervical cancer disparities. Journal of the National Medical Association. 115(2). S19–S25. 5 indexed citations
3.
Graff, Stephanie L., Tanya M. Wildes, Narjust Duma, et al.. (2022). Understanding Modern Medical Centers: Beyond Simone—Intersectional Maxims for a New Era. Journal of Clinical Oncology. 41(7). 1350–1358. 1 indexed citations
4.
Mitchell, Edith, Olatunji B. Alese, Clayton Yates, et al.. (2022). Cancer healthcare disparities among African Americans in the United States. Journal of the National Medical Association. 114(3). 236–250. 35 indexed citations
5.
Sadigh, Gelareh, Kathleen D. Gallagher, Al B. Benson, et al.. (2019). Pilot Feasibility Study of an Oncology Financial Navigation Program in Brain Cancer Patients. Journal of the American College of Radiology. 16(10). 1420–1424. 36 indexed citations
6.
Hecht, J. Randolph, Edith Mitchell, Takayuki Yoshino, et al.. (2015). 5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study. Cancer Management and Research. 7. 165–165. 9 indexed citations
7.
Eng, Cathy, Elżbieta Nowara, Anna Świeboda-Sadlej, et al.. (2011). PRIMARY ANALYSIS AND BIOMARKER EVALUATION: RANDOMIZED PHASE IB/II STUDY OF RILOTUMUMAB (AMG 102) OR GANITUMAB (AMG 479) WITH PANITUMUMAB VERSUS PANITUMUMAB ALONE IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC). Annals of Oncology. 22.
8.
Fogh, Shannon, Gregory J. Kubicek, Walter J. Scott, et al.. (2010). Do Elderly Patients Experience Increased Perioperative or Postoperative Morbidity or Mortality When Given Neoadjuvant Chemoradiation Before Esophagectomy?. International Journal of Radiation Oncology*Biology*Physics. 80(5). 1372–1376. 28 indexed citations
9.
Mitchell, Edith, et al.. (2010). Management of Epidermal Growth Factor Receptor Inhibitor-Induced Dermatologic Toxicity. 1 indexed citations
10.
Lacouture, Mario E., Jonathan Cotliar, & Edith Mitchell. (2007). Clinical management of EGFRI dermatologic toxicities: US perspective.. PubMed. 21(11 Suppl 5). 17–21. 18 indexed citations
11.
Mitchell, Edith, Román Pérez-Soler, Eric Van Cutsem, & Mario E. Lacouture. (2007). Clinical presentation and pathophysiology of EGFRI dermatologic toxicities.. PubMed. 21(11 Suppl 5). 4–9. 45 indexed citations
12.
Morris, Gloria J. & Edith Mitchell. (2007). Bisphosphonate therapy for women with breast cancer and at high risk for osteoporosis.. PubMed. 99(1). 35–45. 4 indexed citations
13.
Mohiuddin, Mohammed, et al.. (2006). 2092. International Journal of Radiation Oncology*Biology*Physics. 66(3). S260–S260. 1 indexed citations
14.
15.
Herlyn, Dorothee, Brigitte Birebent, Nese Akis, et al.. (2003). Colon cancer antigen and anti-idiotype vaccines. PubMed. 21. 287–298. 1 indexed citations
16.
Stein, David E., Najjia N. Mahmoud, Pramila R. Anné, et al.. (2003). Longer Time Interval Between Completion of Neoadjuvant Chemoradiation and Surgical Resection Does Not Improve Downstaging of Rectal Carcinoma. Diseases of the Colon & Rectum. 46(4). 448–453. 97 indexed citations
17.
Desnoyers, Rodwige J., Stephanie Schulz, Jason Y. Park, et al.. (2001). Ectopic Expression of Guanylyl Cyclase C in CD34+ Progenitor Cells in Peripheral Blood. Journal of Clinical Oncology. 19(19). 3951–3959. 41 indexed citations
18.
Birebent, Brigitte, Edith Mitchell, Rajasekharan Somasundaram, et al.. (2001). Anti-idiotypic antibody (Ab2) vaccines: Coupling of Ab2 BR3E4 to KLH increases humoral and/or cellular immune responses in animals and colorectal cancer patients. Journal of Cancer Research and Clinical Oncology. 127(S2). R27–R33. 7 indexed citations
19.
Basak, Sayan, Stephen Eck, Ralf Gutzmer, et al.. (2000). Colorectal Cancer Vaccines: Antiidiotypic Antibody, Recombinant Protein, and Viral Vector. Annals of the New York Academy of Sciences. 910(1). 237–253. 22 indexed citations
20.
Mitchell, Edith, Michael C. Perry, Sharon D. Luikart, et al.. (1996). A phase trial of etoposide and cisplatin in extensive small cell lung cancer: A cancer and Leukemia Group B study. Lung Cancer. 15(2). 215–223. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeltje Schulten Breakdown of academic impact, for papers by Peey‐Sei Kok Breakdown of academic impact, for papers by Matthew E. Witek Breakdown of academic impact, for papers by Claudio Flores Breakdown of academic impact, for papers by Theresa Neumann Breakdown of academic impact, for papers by Hua‐Ling Tsai Breakdown of academic impact, for papers by Leonidas Apostolidis Breakdown of academic impact, for papers by М. Yu. Fedyanin Breakdown of academic impact, for papers by Dayssy A. Diaz Breakdown of academic impact, for papers by Hakaru Tadokoro
Rankless by CCL
2026